Mengqi Xu

The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis.

Hong Zhou, Wenyu Shi, Qingxiu Dang, 2019, Cellular signalling.

A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China

Mengqi Xu, Xiaosu Zhao, F‐M Sun, 2020, Annals of Hematology.

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

Lujun Yang, H. Amin, Xiaoping Sun, 2015, Oncotarget.

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

X. Wan, Yan Zhu, Wenyu Shi, 2019, OncoTargets and therapy.

Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.

Hongming Huang, R. Xu, Li Yang, 2012, Leukemia research.

Dual-response fluorescent probe based on nitrogen-doped carbon dots and europium ions hybrid for ratiometric and on-site visual determination of oxytetracycline and tetracycline.

Yanfeng Tang, C. Tong, Mengqi Xu, 2022, The Science of the total environment.

High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma

Hong Liu, Li Yang, Jianfei Huang, 2017, Annals of Hematology.

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

Lujun Yang, H. Amin, Xiaoping Sun, 2015, Oncotarget.

SemirFL: Boosting Fault Localization via Combining Semantic Information and Information Retrieval

Xiang Chen, Mengqi Xu, Xiaolin Ju, 2022, 2022 IEEE 22nd International Conference on Software Quality, Reliability, and Security Companion (QRS-C).